Johnson & Johnson (JNJ)

JNJ on New York Consolidated

102.20USD
23 Jan 2015
Change (% chg)

$-1.56 (-1.50%)
Prev Close
$103.76
Open
$102.94
Day's High
$102.97
Day's Low
$101.94
Volume
10,125,960
Avg. Vol
8,120,515
52-wk High
$109.49
52-wk Low
$86.09

JNJ

Chart for JNJ

About

Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all... (more)

Overall

Beta: 0.57
Market Cap(Mil.): $286,069.09
Shares Outstanding(Mil.): 2,799.11
Dividend: 0.70
Yield (%): 2.74

Financials

  JNJ Industry Sector
P/E (TTM): 17.93 40.21 40.82
EPS (TTM): 5.70 -- --
ROI: -- 19.07 18.35
ROE: -- 19.85 19.25
Search Stocks

Plaintiffs’ lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK - Lawyers for thousands of women suing Johnson & Johnson’s Ethicon Inc over transvaginal mesh devices are fighting back against the company’s claim that illegal phone solicitations may have resulted in baseless lawsuits.

23 Jan 2015

Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK - Lawyers for thousands of women suing Johnson & Johnson's Ethicon Inc over transvaginal mesh devices are fighting back against the company's claim that illegal phone solicitations may have resulted in baseless lawsuits.

23 Jan 2015

Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK, Jan 23 - Lawyers for thousands of women suing Johnson & Johnson's Ethicon Inc over transvaginal mesh devices are fighting back against the company's claim that illegal phone solicitations may have resulted in baseless lawsuits.

23 Jan 2015

New sponsors ready to replace old say beleaguered FIFA

LONDON - FIFA have rejected suggestions that major sponsors were cutting their ties with the organization because it was a "toxic brand", saying on Friday that they were in advanced negotiations with new sponsors eager to replace the old.

23 Jan 2015

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

21 Jan 2015

Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge

NEW YORK - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial – and ultimately ill-fated – bidding war for device maker Guidant.

21 Jan 2015

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

21 Jan 2015

Stronger dollar hurts J&J's quarterly sales

- Johnson & Johnson reported lower-than-expected quarterly sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.

20 Jan 2015

Johnson & Johnson's forex warning a sign for rival drugmakers

- Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co .

20 Jan 2015

Johnson & Johnson's forex warning a sign for rival drugmakers

Jan 20 - Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co.

20 Jan 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks